We use third-party cookies to provide support. By continuing to browse this website,
you accept our privacy policy.
Adaptive Biotechnologies Corp
18 own
15 watching
Current Price
$9.48
$-0.37
(-3.76%)
1 Week Returns
3 Months Returns
1 Year Returns
Get Started with as little as $1.00
Market Capitalization
1,355.52M
52-Week High
17.79
52-Week Low
5.955
Average Volume
0.69M
Dividend Yield
--
P/E Ratio
7.59259259
Market Capitalization1,355.52M52-Week High17.7952-Week Low5.955Average Volume0.69MDividend Yield--P/E Ratio7.59259259What does the Adaptive Biotechnologies Corp do?
Adaptive Biotechnologies Corporation develops an immune medicine platform for the diagnosis and treatment of various diseases. The company offers immunoSEQ research service and kit that is used to answer research questions that inform current and future clinical trials, as well as to discover new prognostic and diagnostic signals. It also provides clonoSEQ diagnostic tests, which include immunosequencing services for use in the detection and monitoring of minimal residual disease in patients with select blood cancers. In addition, the company offers a pipeline of clinical products and services that are used for the diagnosing, monitoring, and treatment of diseases, such as cancer, autoimmune conditions, and infectious diseases. Adaptive Biotechnologies Corporation has strategic collaborations with Genentech, Inc. for the development, manufacture, and commercialization of neoantigen directed T cell therapies for the treatment of a range of cancers; and Microsoft Corporation to develop diagnostic tests for the early detection of various diseases from a single blood test. It serves the life sciences research, clinical diagnostics, and drug discovery customers. The company was formerly known as Adaptive TCR Corporation and changed its name to Adaptive Biotechnologies Corporation in December 2011. Adaptive Biotechnologies Corporation was founded in 2009 and is headquartered in Seattle, Washington.
Read More
How much money does Adaptive Biotechnologies Corp make?
News & Events about Adaptive Biotechnologies Corp.
Ticker Report
1month ago
Adaptive Biotechnologies Co. (NASDAQ:ADPT Get Rating) was the recipient of a large decline in short interest in December. As of December 15th, there was short interest totalling 4,730,000 shares, a decline of 11.1% from the November 30th total of 5,320,000 shares. Based on an average trading...
Zolmax
1month ago
Adaptive Biotechnologies Co. (NASDAQ:ADPT Get Rating) saw a large decrease in short interest during the month of December. As of December 15th, there was short interest totalling 4,730,000 shares, a decrease of 11.1% from the November 30th total of 5,320,000 shares. Based on an average daily trading...
PR Newswire
1month ago
Thinking about buying stock in HTG Molecular Diagnostics, 180 Life Sciences, Six Flags Entertainment, Under Armour, or Adaptive Biotechnologies? Thinking about buying stock in HTG Molecular Diagnostics, 180 Life Sciences, Six Flags Entertainment, Under Armour, or Adaptive Biotechnologies? PR...
Globe Newswire
1month ago
Multiple presentations reinforce clonoSEQs ability to provide valuable insights for treatment surveillance and clinical decision-makingMore than 30 clonoSEQ-related abstracts to be presented at the meeting SEATTLE, Dec. 10, 2022 (GLOBE NEWSWIRE) -- Adaptive Biotechnologies Corporation (Nasdaq: ADPT...
Globe Newswire
2 months ago
clonoSEQ is the first and only MRD test in DLBCL with Medicare coverage across all lines of therapy, treatment regimens, and timepointsAdaptive now accepts blood samples from DLBCL patients in Streck tubes that stabilize ctDNA SEATTLE, Dec. 01, 2022 (GLOBE NEWSWIRE) -- Adaptive Biotechnologies ...
Frequently Asked Questions
Frequently Asked Questions
What is Adaptive Biotechnologies Corp share price today?
Can Indians buy Adaptive Biotechnologies Corp shares?
How can I buy Adaptive Biotechnologies Corp shares from India?
Can Fractional shares of Adaptive Biotechnologies Corp be purchased?
What are the documents required to start investing in Adaptive Biotechnologies Corp stocks?
What is today’s traded volume of Adaptive Biotechnologies Corp?
What is today’s market capitalisation of Adaptive Biotechnologies Corp?
What is the 52-Week High and Low Range of Adaptive Biotechnologies Corp?
What percentage is Adaptive Biotechnologies Corp down from its 52-Week High?
What percentage is Adaptive Biotechnologies Corp up from its 52-Week Low?
Current Price
$9.48
$-0.37
(-3.76%)
1 Week Returns
3 Months Returns
1 Year Returns
Get Started with as little as $1.00
Related Stocks
Sign up and dive into a whole new world of investing.
Join over 280,000 who have signed up and are using Stockal successfully already.
Related Stocks
Sign up and dive into a whole new world of investing.
Join over 280,000 who have signed up and are using Stockal successfully already.